These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Monovalent Pseudomonas aeruginosa vaccines in the treatment of otolaryngeal infections with Pseudomonas aeruginosa. Cincă D; Meitert E; Tomescu E; Meitert T; Suciu M; Sima F; Savulian C; Midan F; Lică I Arch Roum Pathol Exp Microbiol; 1982; 41(3):277-84. PubMed ID: 6818930 [No Abstract] [Full Text] [Related]
25. Characterisation of mouse monoclonal antibodies produced by immunisation with a single serotype component of a polyvalent Pseudomonas aeruginosa vaccine. Barclay GR; Yap PL; McClelland DB; Jones RJ; Roe EA; McCann MC; Micklem LR; James K J Med Microbiol; 1986 Feb; 21(1):87-90. PubMed ID: 3081727 [TBL] [Abstract][Full Text] [Related]
26. Pseudomonas aeruginosa infection and vaccination in the rat. Kostiala AA J Med Microbiol; 1980 May; 13(2):201-12. PubMed ID: 6770090 [TBL] [Abstract][Full Text] [Related]
27. A polyvalent Pseudomonas vaccine. Sato H; Diena BB Rev Can Biol; 1974 Jun; 33(2):93-7. PubMed ID: 4211759 [No Abstract] [Full Text] [Related]
28. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients. Hunt JL; Purdue GF J Trauma; 1988 Feb; 28(2):146-51. PubMed ID: 3126302 [TBL] [Abstract][Full Text] [Related]
40. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin]. Moroz AF; Kharitonova AM; Chanturiia TsK Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]